Peroxisome Proliferator-Activated Receptor-&ggr; (PPAR-&ggr;) Agonists on Glycemic Control, Lipid Profile and Cardiovascular Risk

Publisher： Bentham Science Publishers

E-ISSN： 1874-4702|5|2|272-281

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.5, Iss.2, 2012-01, pp. : 272-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PPAR-&ggr; Agonists as Regulators of Microglial Activation and Brain Inflammation

By  

Current Pharmaceutical Design, Vol. 12, Iss. 1, 2006-01 ,pp. : 93-109

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR)&bgr; /&dgr;: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome

By  

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 46-55

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Agonists as Therapeutic Agents for Cardiovascular Disorders: Focus on Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 23, Iss. 7, 2017-04 ,pp. : 1119-1124

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR) Agonists as Promising New Medications for Drug Addiction: Preclinical Evidence

By  

Current Drug Targets, Vol. 14, Iss. 7, 2013-06 ,pp. : 768-776

Bentham Science Publishers

Access to resources Recommend Favorite

Enantioselective Synthesis of PPAR (Peroxisome Proliferator-Activated Receptors) Agonists and Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 10, 2014-05 ,pp. : 1283-1293

Bentham Science Publishers

Access to resources Recommend Favorite